Lv1
70 积分 2022-03-30 加入
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
5个月前
已完结
Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia? Response to Tandon
5个月前
已关闭
eNRGy: Making progress toward a future for NRG1 fusion-positive cancer
7个月前
已关闭
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
7个月前
已完结
Artificial Intelligence in Accelerating Drug Discovery and Development
7个月前
已完结
皖公网安备34019202002308
